Bard Surgical Mesh Settlement Results in $60M Payment To States
C.R. Bard will pay $60 million to resolve claims with most states that its transvaginal mesh products were deceptively advertised.
C.R. Bard will pay $60 million to resolve claims with most states that its transvaginal mesh products were deceptively advertised.
Ethicon has reached an undisclosed settlement in a federal vaginal mesh bellwether trial just a day after it was hit with a nearly $6 million verdict in a similar case.